Beranda › Gagal Jantung › Florida › Orlando
Uji klinis Gagal Jantung di Orlando, FL
16 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Orlando (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Menerima pesertaFase 3
- Flourish Research, Winter Park · 5 mi jauhnya
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Menerima pesertaFase 1
- Flourish Research, Winter Park · 5 mi jauhnya
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Menerima pesertaFase 3
- Flourish Research, Winter Park · 5 mi jauhnya
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Menerima pesertaFase 2
- AdventHealth Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi jauhnya
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Menerima pesertaFase 3
- AdventHealth, Orlando
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Menerima pesertaFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · 5 mi jauhnya
- dan 1 lainnya
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Menerima pesertaFase 3
- Research Site, Orlando
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Menerima peserta
- Advent Health, Orlando
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Menerima peserta
- Orlando Health, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi jauhnya
- K2 Medical Research, Maitland · 6 mi jauhnya
Alleviant ALLAY-HF Study
Menerima peserta
- Advent Health Orlando, Orlando
Assessment of CCM in HF With Higher Ejection Fraction
Menerima peserta
- AdventHealth Orlando, Orlando
- Revival Clinical Research, Orlando
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Menerima pesertaFase 2
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi jauhnya
CCM OPEN HF Registry
Menerima pesertaStudi observasional
- AdventHealth Orlando, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Menerima peserta
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Menerima pesertaFase 3
- AdventHealth, Orlando
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Studi lain di Orlando
- Kanker Paru Non-Sel Kecil44 studi
- Obesitas31 studi
- Kanker Metastatik29 studi
- Kelebihan Berat Badan27 studi
- Penyakit Alzheimer25 studi
- Diabetes Tipe 224 studi
- Kanker (semua jenis)24 studi
- Kanker Payudara23 studi
- Kanker Ovarium22 studi
- Kolitis Ulseratif22 studi
- Kanker Paru21 studi
- Kanker Kolorektal19 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.